[HTML][HTML] Repurposing sigma-1 receptor ligands for COVID-19 therapy?

JM Vela - Frontiers in Pharmacology, 2020 - frontiersin.org
Outbreaks of emerging infections, such as COVID-19 pandemic especially, confront health
professionals with the unique challenge of treating patients. With no time to discover new …

[HTML][HTML] Glutathione supplementation as an adjunctive therapy in COVID-19

V Guloyan, B Oganesian, N Baghdasaryan, C Yeh… - Antioxidants, 2020 - mdpi.com
Morbidity and mortality of coronavirus disease 2019 (COVID-19) are due in large part to
severe cytokine storm and hypercoagulable state brought on by dysregulated host …

[HTML][HTML] Novel coronavirus disease (COVID-19) pandemic: A recent mini review

MF ur Rehman, C Fariha, A Anwar, N Shahzad… - Computational and …, 2021 - Elsevier
The COVID-19, caused by a novel coronavirus, was declared as a global pandemic by WHO
more than five months ago, and we are still experiencing a state of global emergency. More …

COVID‐19: A systematic review and update on prevention, diagnosis, and treatment

H Aghamirza Moghim Aliabadi… - MedComm, 2022 - Wiley Online Library
Since the rapid onset of the COVID‐19 or SARS‐CoV‐2 pandemic in the world in 2019,
extensive studies have been conducted to unveil the behavior and emission pattern of the …

[HTML][HTML] Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World

MF Rehman, S Akhter, AI Batool, Z Selamoglu… - Antibiotics, 2021 - mdpi.com
The SARS CoV-2 pandemic has affected millions of people around the globe. Despite many
efforts to find some effective medicines against SARS CoV-2, no established therapeutics …

Reported adverse drug reactions associated with the use of hydroxychloroquine and chloroquine during the COVID-19 pandemic

J Perez, M Roustit, M Lepelley, B Revol… - Annals of Internal …, 2021 - acpjournals.org
Background: A few weeks after the beginning of the outbreak of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), uncontrolled trials and in vitro studies suggested …

[HTML][HTML] Explaining the challenges of resources management and its underlying factors in COVID-19 era in Iran: a qualitative study

V Vatandoost, SS Tabatabaee, M Okhovati… - BMC Public Health, 2023 - Springer
Background Identifying factors affecting health costs can contribute to formulating the best
policies for controlling and managing health costs. To this end, the present study aimed to …

[HTML][HTML] Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021

É Schultz, L Atlani-Duault, P Peretti-Watel, JK Ward - Therapies, 2022 - Elsevier
Objectives In the early stages of the coronavirus disease 2019 (COVID-19) pandemic,
chloroquine and its derivatives such as hydroxychloroquine (HCQ) were widely commented …

Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: a review

L Grange, P Guilpain, ME Truchetet, JL Cracowski… - Therapies, 2020 - Elsevier
Summary Since December 2019, the COVID-19 pandemic has become a major public
health problem. To date, there is no evidence of a higher incidence of COVID in patients with …

Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World.

S Akhter, AI Batool, Z Selamoglu… - Antibiotics (2079 …, 2021 - search.ebscohost.com
The SARS CoV-2 pandemic has affected millions of people around the globe. Despite many
efforts to find some effective medicines against SARS CoV-2, no established therapeutics …